Loading...
Bienvenue dans la collection HAL Infinity
Recherche en Immunologie, Inflammation et Maladies Infectieuses : du fondamental au translationnel
L’Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), créé au 1er janvier 2021, résulte de la fusion de deux unités de recherche localisées sur le campus Purpan, le Centre de Physiopathologie Toulouse Purpan (CPTP) et l’Unité de Différenciation Epithéliale et Autoimmunité Rhumatoïde (UDEAR).
Nombre de fichiers déposés
Dernières publications
-
Rémi Nguyen Van, Pauline Houssel‐debry, Domitille Erard, Jérôme Dumortier, Anne Pouvaret, et al.. Characteristics, management, and outcome of tuberculosis after liver transplant: a case series and literature review. Infectious Diseases Now, 2024, Infectious Diseases Now, 54 (3), pp.104869. ⟨10.1016/j.idnow.2024.104869⟩. ⟨hal-04483646⟩
-
Damien Caillet Portillo, Xavier Puéchal, Maëva Masson, Marie Kostine, Alexia Michaut, et al.. Diagnosis and treatment of Tropheryma whipplei infection in patients with inflammatory rheumatic disease: Data from the French Tw-IRD registry. Journal of Infection, 2024, 88 (2), pp.132-138. ⟨10.1016/j.jinf.2023.12.010⟩. ⟨hal-04495049⟩
-
Joanna Kedra, Philippe Dieudé, Caroline Giboin, Hubert Marotte, Carine Salliot, et al.. Towards the lowest efficacious dose (ToLEDo): results of a multicenter non‐inferiority randomized open‐label controlled trial assessing Tocilizumab or Abatacept injection spacing in rheumatoid arthritis in remission. Arthritis & rheumatology, 2024, ⟨10.1002/art.42752⟩. ⟨hal-04279434⟩
Nombre de notices déposée
933
Taux d'open access
75 %
Sujets
Ribavirin
Safety
Regulatory T cells
Allergy
Multiple sclerosis
Obesity
Skin
Hepatitis E
Male
Statistical model
Cytomegalovirus
Epidemiology
Chronic kidney disease
T lymphocytes
Microphthalmia
Lymphocytes
Atopic dermatitis
Actin cytoskeleton
HIV-1
Psoriasis
Immunology
Infection
Filaggrin
Prevention
Pregnancy
Children
France
Congenital infection
Preeclampsia
Cytokines
ACPA
Metabolism
Mutation
Autoantibodies
Diagnosis
Biomarkers
Age
Public health
Autoimmune diseases
Kidney transplantation
IgE
Cameroon
SARS-CoV-2
Epidermis
Inflammation
Lipids
Risk factors
Antigen presentation
Infectious disease
Cancer
Dendritic cells
AIDS
Dog
Hepatitis E virus
Apoptosis
Extracellular vesicles
Systemic lupus erythematosus
Vaccine
Ant-CCP
Prader-Willi syndrome
Omicron
Plasmodium falciparum
Cholesterol
HIV
Immunosuppression
Macrophages
Mast cells
Staphylococcus aureus
Liver transplantation
Transplantation
Oxidative stress
Dupilumab
Macrophage
Rheumatoid arthritis
Humans
Signaling
Anaphylaxis
Immune response
Autoimmunity
Mast cell
Malaria
Monocyte
Treatment
Thymus
Asthma
Female
Organ transplantation
Prevalence
T cells
Outcome
Anophthalmia
Escherichia coli
Toxoplasma gondii
Placenta
Innate immunity
Immunotherapy
Differentiation
COVID-19
Immunological synapse
NK cells